未登录

V

Victoria I. Bunik

Sechenov First Moscow State Medical University

H指数:33

被引数:3,990

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Relationships of GDAP1 Mutations to Disease Phenotype and Mechanisms of Therapeutic Action of Oxidative Metabolism Activators in a Patient with Charcot-Marie-Tooth Neuropathy Type 2K

BIOCHEMISTRY-MOSCOW

IF2.2

2025-11-010

PRE

Kinetic Characterization of Inhibition of Cathepsins L and S by Peptides With Anticancer Potential

Cathepsins L和S被具有抗癌潜力的肽抑制的动力学表征

PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS

IF2.8

2025-09-010

PRE

Thiamine, gastrointestinal beriberi and acetylcholine signaling

硫胺素、胃肠型脚气病及乙酰胆碱信号传导

FRONTIERS IN NUTRITION

IF5.1

2025-04-090

OA

A challenging interplay between basic research, technologies and medical education to provide therapies based on disease mechanisms

FRONTIERS IN MEDICINE

IF3

2024-08-200

OAAI

Experts' opinion in medicine 2022

FRONTIERS IN MEDICINE

IF3

2023-10-101

OAAI

The Therapeutic Potential of Vitamins B1, B3 and B6 in Charcot-Marie-Tooth Disease with the Compromised Status of Vitamin-Dependent Processes

维生素B1，B3和B6在charcot-marie-tooth病中的治疗潜力，并具有维生素依赖性过程的受损状态

IF3.5

2023-06-225

OAAI

Predictive markers for efficiency of the amino-acid deprivation therapies in cancer

FRONTIERS IN MEDICINE

IF3

2022-11-0310

OAAI

Editorial: Women in science - translational medicine 2021

FRONTIERS IN MEDICINE

IF3

2022-09-070

OAAI

Administration of Phosphonate Inhibitors of Dehydrogenases of 2-Oxoglutarate and 2-Oxoadipate to Rats Elicits Target-Specific Metabolic and Physiological Responses

FRONTIERS IN CHEMISTRY

IF4.2

2022-06-203

OAAI

Delayed Impact of 2-Oxoadipate Dehydrogenase Inhibition on the Rat Brain Metabolism Is Linked to Protein Glutarylation

FRONTIERS IN MEDICINE

IF3

2022-06-018

OAAI

Efficient Assay and Marker Significance of NAD+ in Human Blood

FRONTIERS IN MEDICINE

IF3

2022-05-197

OAAI

Increasing Inhibition of the Rat Brain 2-Oxoglutarate Dehydrogenase Decreases Glutathione Redox State, Elevating Anxiety and Perturbing Stress Adaptation

PHARMACEUTICALS

IF4.8

2022-01-3111

OAAI

Inhibition of 2-Oxoglutarate Dehydrogenase as a Chemical Model of Acute Hypobaric Hypoxia

FRONTIERS IN MEDICINE

IF3

2021-12-173

OAAI

Physiological and Biochemical Markers of the Sex-Specific Sensitivity to Epileptogenic Factors, Delayed Consequences of Seizures and Their Response to Vitamins B1 and B6 in a Rat Model

PHARMACEUTICALS

IF4.8

2021-07-2812

OAAI

Severe Spinal Cord Injury in Rats Induces Chronic Changes in the Spinal Cord and Cerebral Cortex Metabolism, Adjusted by Thiamine That Improves Locomotor Performance

FRONTIERS IN MOLECULAR NEUROSCIENCE

IF3.8

2021-03-2921

OAAI

Selective Inhibition of 2-Oxoglutarate and 2-Oxoadipate Dehydrogenases by the Phosphonate Analogs of Their 2-Oxo Acid Substrates

FRONTIERS IN CHEMISTRY

IF4.2

2021-01-1210

OAAI

Suppressing endoplasmic reticulum stress-related autophagy attenuates retinal light injury

IF3.9

2020-08-2833

OAAI

Molecular characterization of pyridoxine 5′-phosphate oxidase and its pathogenic forms associated with neonatal epileptic encephalopathy

SCIENTIFIC REPORTS

IF3.9

2020-08-1221

OAAI

Synthetic analogues of 2-oxo acids discriminate metabolic contribution of the 2-oxoglutarate and 2-oxoadipate dehydrogenases in mammalian cells and tissues

SCIENTIFIC REPORTS

IF3.9

2020-02-0525

OAAI

Hypoxic Adaptation of Mitochondrial Metabolism in Rat Cerebellum Decreases in Pregnancy

IF5.2

2020-01-0717

OAAI